Spinal anaesthesia developed in the late 1800s with the work of Wynter, Quincke and Corning. However, it was the German surgeon, Karl August Bier in 1898, who probably gave the ®rst spinal anaesthetic. Bier also gained ®rst-hand experience of the disabling headache related to dural puncture. He correctly surmised that the headache was related to excessive loss of cerebrospinal¯uid (CSF). In the last 50 yr, the development of ®ne-gauge spinal needles and needle tip modi®cation, has enabled a signi®cant reduction in the incidence of post-dural puncture headache. Though it is clear that reducing the size of the dural perforation reduces the loss of CSF, there are many areas regarding the pathogenesis, treatment and prevention of post-dural puncture headache that remain contentious. How does the microscopic pattern of collagen alignment in the spinal dura affect the dimensions of the dural perforation? How do needle design, size and orientation in¯uence leakage of CSF through the dural perforation? Can pharmacological methods reduce the symptoms of post-dural puncture headache? By which mechanism does the epidural blood patch cure headache? Is there a role for the prophylactic epidural blood patch? Do epidural saline, dextran, opioids and tissue glues reduce the rate of CSF loss? This review considers these contentious aspects of post-dural puncture headache. 
History
Spinal anaesthesia developed in the late 1800s. In 1891, Wynter and Quincke 95 aspirated cerebrospinal¯uid (CSF) from the subarachnoid space for the treatment of raised intracranial hypertension associated with tuberculous meningitis. The catheters and trochars used were probably about 1 mm in diameter and would certainly have led to a post-dural puncture headache. However, all Quincke and Wynters' subjects died soon after.
In 1895, John Corning, a New York physician specializing in diseases of the mind and nervous system, proposed that local anaesthesia of the spinal cord with cocaine may have therapeutic properties. 50 Corning injected cocaine 110 mg at the level of the T11/12 interspace in a man to treat habitual masturbation. Despite being accredited with the ®rst spinal anaesthetic, it is unlikely from his description and the dose of cocaine that his needle entered the subarachnoid space. 82 In August 1898, Karl August Bier, 137 a German surgeon, injected cocaine 10±15 mg into the subarachnoid space of seven patients, himself and his assistant, Hildebrandt. Bier, Hildebrandt and four of the subjects all described the symptoms associated with postdural puncture headache. Bier surmised that the headache was attributable to loss of CSF. By the early 1900s, there were numerous reports in the medical literature of the application of spinal anaesthesia using large spinal needles. 75 Headache was reported to be a complication in 50% of subjects. At that time, the headache was said to resolve within 24 h.
Ether anaesthesia was introduced into obstetric practice in 1847, shortly after Morton's public demonstration. Despite the obvious advantages of regional anaesthesia for the relief of labour pain, it was not until a Swiss obstetrician in 1901 used intrathecal cocaine for the relief of pain in the second stage of labour that regional anaesthesia for obstetrics was popularized. 49 Though both vomiting and a high incidence of post-dural puncture headache were noted, it was the high mortality rate in Caesarean deliveries performed under spinal anaesthesia (1 in 139) that led to the abandonment of this technique in the 1930s. The period from 1930 to 1950 has often been referred to as the`dark ages of obstetric anaesthesia', when natural childbirth and psychoprophylaxis were encouraged.
In 1951, Whitacre and Hart 59 developed the pencil-point needle, based on the observations of Greene 53 in 1926. Developments in needle design since that time have led to a signi®cant reduction in the incidence of post-dural puncture headache. However, dural puncture headache remains a disabling complication of needle insertion into the subarachnoid space.
Pathophysiology of dural puncture

Anatomy of the spinal dura mater
The spinal dura mater is a tube extending from the foramen magnum to the second segment of the sacrum. It contains the spinal cord and nerve roots that pierce it. The dura mater is a dense, connective tissue layer made up of collagen and elastic ®bres. The classical description of the spinal dura mater is of collagen ®bres running in a longitudinal direction. 53 This had been supported by histological studies of the dura mater. 93 Clinical teaching based upon this view of the dura recommends that a cutting spinal needle be orientated parallel rather than at right angles to these longitudinal dural ®bres. Orientating the needle at right angles to the parallel ®bres, it was said would cut more ®bres. The cut dural ®bres, previously under tension, would then tend to retract and increase the longitudinal dimensions of the dural perforation, increasing the likelihood of a postspinal headache. Clinical studies had con®rmed that postdural puncture headache was more likely when the cutting spinal needle was orientated perpendicular to the direction of the dural ®bres. However, recent light and electron microscopic studies of human dura mater have contested this classical description of the anatomy of the dura mater. 102 These studies describe the dura mater as consisting of collagen ®bres arranged in several layers parallel to the surface. Each layer or lamellae consists of both collagen and elastic ®bres that do not demonstrate speci®c orientation. 43 The outer or epidural surface may indeed have dural ®bres arranged in a longitudinal direction, but this pattern is not repeated through successive dural layers. Recent measurements of dural thickness have also demonstrated that the posterior dura varies in thickness, and that the thickness of the dura at a particular spinal level is not predictable within an individual or between individuals. 102 Dural perforation in a thick area of dura may be less likely to lead to a CSF leak than a perforation in a thin area, and may explain the unpredictable consequences of a dural perforation.
Cerebrospinal¯uid
CSF production occurs mainly in the choroid plexus, but there is some evidence of extrachoroidal production. About 500 ml of CSF is produced daily (0.35 ml min ±1 ). The CSF volume in the adult is approximately 150 ml, of which half is within the cranial cavity. 
Dura mater and response to trauma
The consequences of perforation of the spinal or cranial dura are that there will be leakage of CSF. Neurosurgical experience of dural perforation is that even minor perforations need to be closed, either directly or through the application of synthetic or biological dural graft material. Failure to close the dural perforation may lead to adhesions, continuing CSF leak, and the risk of infection. There are few experimental studies of the response of the dura to perforation. 70 In 1923, it was noted that deliberate dural defects in the cranial dura of dogs took approximately one week to close. The closure was facilitated through ®broblastic proliferation from the cut edge of the dura. Work published in 1959 70 dismissed the notion that the ®broblastic proliferation arose from the cut edge of the dura. This study maintained that the dural repair was facilitated by ®broblastic proliferation from surrounding tissue and blood clot. The study also noted that dural repair was promoted by damage to the pia arachnoid, the underlying brain and the presence of blood clot. It is therefore possible that a spinal needle carefully placed in the subarachnoid space does not promote dural healing, as trauma to adjacent tissue is minimal. Indeed, the observation that blood promotes dural healing agrees with Gormley's original observation that bloody taps were less likely to lead to a post-dural puncture headache as a consequence of a persistence CSF leak. 51 
Needle tip deformation and dural perforation
It has been proposed that contact with bone during insertion may lead to spinal needle tip deformation. 67 90 Damaged needle tips could lead to an increase in the size of the subsequent dural perforation. Recent in vivo studies have demonstrated that the cutting type spinal needle is more likely to be deformed after bony contact than comparable sized pencil-point needles. 90 However, no in vivo 67 or in vitro work has yet demonstrated an increase in the size of dural perforation where damaged needles are used.
Consequences of dural puncture
Puncture of the dura has the potential to allow the development of excessive leakage of CSF. Excess loss of CSF leads to intracranial hypotension and a demonstrable reduction in CSF volume. 52 After the development of postdural puncture headache, the presence of a CSF leak has been con®rmed with radionuclide cisternography, radionuclide myelography, manometric studies, epiduroscopy and direct visualization at laminectomy. The adult subarachnoid pressure of 5±15 cm H 2 0 is reduced to 4.0 cm H 2 0 or less. 100 The rate of CSF loss through the dural perforation 29 (0.084±4.5 ml s ±1 ) is generally greater than the rate of CSF production (0.35 ml min ±1 ), particularly with needle sizes larger than 25G. 29 101 Gadolinium-enhanced MRI, in the presence of a postdural puncture headache, frequently demonstrates`sagging' of the intracranial structures. The MRI may or may not demonstrate meningeal enhancement. 56 The meningeal enhancement is attributable to vasodilatation of thin-walled vessels in response to the intracranial hypotension. Histological studies have con®rmed that the vasodilation of meningeal vessels is unrelated to an in¯ammatory response. 56 Although the loss of CSF and lowering of CSF pressure is not disputed, the actual mechanism producing the headache is unclear. There are two possible explanations. First, the lowering of CSF pressure causes traction on the intracranial structures in the upright position. These structures are pain sensitive, leading to the characteristic headache. Secondly, the loss of CSF produces a compensatory venodilatation vis-a Á-vis the Monro±Kellie doctrine. 52 The Monro±Kellie doctrine, or hypothesis, states that the sum of volumes of the brain, CSF, and intracranial blood is constant. The consequence of a decrease in CSF volume is a compensatory increase in blood volume. The venodilatation is then responsible for the headache.
Incidence
The incidence of post-dural puncture headache was 66% in 1898. 137 This alarmingly high incidence of post-spinal headache was likely attributable to the use of large gauge, medium bevel, cutting spinal needles (needles 5, 6 and 7, Fig. 1 ). In 1956, with the introduction of 22G and 24G needles, the incidence was estimated to be 11%. 132 Today the use of ®ne gauge pencil-point needles, such as the Whitacre and Sprotte â has produced a greater reduction in the incidence of post-dural puncture headache, which varies with the type of procedure and patients involved. It is related to the size and design of the spinal needle used ( Fig. 1; Table 1 ), 36 the experience of the personnel performing the dural puncture, 35 and the age and sex of the patient.
Spinal anaesthesia
Anaesthetists have been active in attempting to reduce the incidence of post-spinal headache. Reducing the size of the spinal needle has made a signi®cant impact on the incidence of post-spinal headache. The incidence is~40% with a 22G needle; 25% with a 25G needle; 4 44 2%±12% with a 26G Quincke needle; 4 45 and <2% with a 29G needle. 47 However, technical dif®culties leading to failure of the spinal anaesthetic are common with needles of 29G or smaller. 47 In 1951, Whitacre and Hart 59 introduced thè atraumatic' spinal needle (needle 3, Fig. 1 ). This design offered the handling characteristics of larger needles with a low incidence of post-spinal headache (Table 1 ). Needle modi®cations since that time, such as the Sprotte â119 and Atraucan â63 needles, promise further reductions in postspinal headache.
Diagnostic lumbar puncture
The acceptance of small gauge needles for diagnostic lumbar puncture has been slow to develop. Until recently, diagnostic lumbar puncture was commonly performed with a 20G or even 18G medium bevel cutting needle with a high incidence of post-spinal headache. A recent publication promoted the virtues of a 20G needle for reducing the incidence of dural puncture headache! 125 Though anaesthetists are in general critical of the use of large gauge needles for lumbar puncture, 105 neurologists maintain that adequate¯ow of CSF can only be achieved with spinal needles of 22G or greater. 18 
Obstetrics
The parturient is at particular risk of dural puncture and the subsequent headache because of their sex, young age, and the widespread application of epidural anaesthesia. 44 In parturients receiving epidural anaesthesia, the incidence of dural puncture is between 0 and 2.6%. 104 The incidence is inversely related to the experience of the anaesthetist, 80 and is said to be reduced by orientation of the needle bevel parallel to the dural ®bres. 87 Loss of resistance to air confers a higher risk of dural puncture than loss of resistance tō uid. 105 After a dural puncture with a 16G Tuohy needle, up to 70% of subjects will report symptoms related to low CSF pressure. 26 Despite the high incidence of headache consequent upon dural puncture with a Tuohy needle, the anaesthetist needs to consider a differential diagnosis, as intracranial haematoma, 65 or tumour 38 presenting with similar symptoms to, or in association with, a post-dural puncture headache have been described.
In the presence of a known dural puncture, it is often recommended that pushing in the second stage should be avoided. 88 The evidence to support this assertion is far from conclusive, and anger from the parturient about the medicalization of her labour is best avoided. 26 133 Children Post-dural puncture headache is reported as uncommon in children.
14 Although low CSF pressure or other physiological differences have been proffered as reasons to explain the low incidence in children, it is likely that a low reporting rate is the explanation. Groups that have explored the incidence of post-spinal headaches in children have found rates comparable to young adults. 73 
Prevention
Spinal needles have undergone numerous modi®cations in recent years, the aim being to reduce the incidence of dural puncture headache. The principal factor responsible for the development of a dural puncture headache is the size of the dural perforation. Other factors such as the shape of the dural perforation and the orientation of the spinal needle have a less signi®cant role.
Needle size
Large spinal needles will clearly produce large dural perforations where the likelihood of a dural puncture headache is high. Conversely, the smaller needles produce small dural perforations with a lower incidence of headache. Fine gauge spinal needles, 29G or smaller, are technically more dif®cult to use, 64 and for spinal anaesthesia at least, are associated with a high failure rate. 45 A balance has to be struck between the risks of dural puncture headache and technical failure. 25G, 26G and 27G 69 needles probably represent the optimum needle size for spinal anaesthesia. Neurologists argue that for the purposes of aspiration of CSF and measurement of CSF pressure, 22G needles are the smallest practical needles.
Needle orientation
There are many clinical, 79 87 and laboratory, 36 101 studies that lend credence to the hypothesis that perpendicular orientation of the bevel of a spinal or epidural needle leads to a reduction in the incidence of post-dural puncture headache.
Needle design
Over the years since Quincke and Bier, a large number of needle designs have been introduced. The Quincke type is the standard needle with a medium cutting bevel and the ori®ce at the needle tip (needle 7, Fig. 1 ). In 1926, Greene 53 proposed a needle tip design with a non-cutting edge that would separate the dural ®bres to avoid post-dural puncture headache. In 1951, the Whitacre needle was introduced and, in 1987, the Sprotte needle. The generic term for these needles is pencil-point or atraumatic, though in truth they are neither. The Whitacre needle (needle 3, Fig. 1 ) has a diamond shaped tip, and the Sprotte needle (needle 2, Fig. 1 ) tip is conical. The ori®ce is up to 0.5 mm from the needle tip. Clinical and laboratory 29 studies have con®rmed that pencil-point needles produce fewer post-dural puncture headaches than medium bevel cutting needles. However, there are disadvantages. Paraesthesia has been observed with the pencil-point needles. 115 The reason may lie in the distance from the tip of the needle to the ori®ce. The tip has to be passed at least 0.5 mm into the subarachnoid space before the ori®ce enters the subarachnoid space. The tip then has the opportunity to impinge upon the stretched cauda equina. Giving credence to this hypothesis, paraesthesia is uncommon with the short bevel needles or the Atraucan â needle. 115 The problem of low CSF¯ow and paraesthesia seen with the pencil-point needles has promoted the search for novel needle designs. The Atraucan â (needle 1, Fig. 1 ) has recently been marketed. It has an ori®ce at the tip of the needle. The Atraucan â has a narrow cutting tip and an atraumatic bevel. Initial reports of these needles are promising as regards ease of use and low dural puncture headache rate.
Operator skill level and fatigue
It has been suggested that the incidence of inadvertent dural puncture during epidural anaesthesia is inversely related to operator experience. 104 However, sleep deprivation, operator fatigue and the effect of night work may be a confounding variable producing the higher incidence of inadvertent dural puncture in junior personnel performing epidural analgesia.
Presentation of dural puncture headache
Onset
Headache and backache are the dominant symptoms that develop after accidental dural puncture. Ninety per cent of headaches will occur within 3 days of the procedure, 104 and 66% start within the ®rst 48 h. 76 Rarely, the headache develops between 5 and 14 days after the procedure. Headache may present immediately after dural puncture. 133 However, this is rare, and its occurrence should alert the physician to alternative causes.
Symptoms
Headache is the predominant, but not ubiquitous presenting complaint. 83 The headache is described as severe,`searing and spreading like hot metal'. 133 The common distribution is over the frontal and occipital areas radiating to the neck and shoulders. The temporal, vertex and nuchal areas are reported less commonly as the site of discomfort, although neck stiffness may be present. The pain is exacerbated by head movement, and adoption of the upright posture, and relieved by lying down. An increase in severity of the headache on standing is the sine qua non of post-dural puncture headache.
Other symptoms associated with dural puncture headache include nausea, vomiting, hearing loss, 78 tinnitus, vertigo, dizziness and paraesthesia of the scalp, and upper 108 and lower limb pain. Visual disturbances such as diplopia or cortical blindness have been reported. 132 Cranial nerve palsies are not uncommon. 16 Two cases of thoracic back pain without headache have been described. 37 Neurological symptoms may precede the onset of grand mal seizures. Intracranial subdural haematomas, cerebral herniation and death, 39 have been described as a consequence of dural puncture. Unless a headache with postural features is present, the diagnosis of post-dural puncture headache should be questioned, as other serious intracranial causes for headache must be excluded. 3 
Diagnosis
The history of accidental or deliberate dural puncture and symptoms of a postural headache, neck ache and the presence of neurological signs, usually guide the diagnosis. Where there is doubt regarding the diagnosis of post-dural puncture headache, additional tests may con®rm the clinical ®ndings. A diagnostic lumbar puncture may demonstrate a low CSF opening pressure or a`dry tap', a slightly raised CSF protein, and a rise in CSF lymphocyte count. An MRI may demonstrate: diffuse dural enhancement, with evidence of a sagging brain; descent of the brain, optic chiasm, and brain stem; obliteration of the basilar cisterns; and enlargement of the pituitary gland. 85 CT myelography, retrograde radionuclide myelography, cisternography, or thin section MRI 130 can be used to locate the spinal source of the CSF leak.
Differential diagnosis
The diagnosis of post-dural puncture headache is frequently clear from the history of dural puncture and the presence of a severe postural headache. However, it is important to consider alternative diagnoses (Table 2) as serious intracranial pathology may masquerade as a post-dural puncture headache. Clinicians should remember that intracranial hypotension can lead to intracranial haemorrhage through tearing of bridging dural veins, 65 94 and a delay in diagnosis and treatment can be dangerous. Diagnoses that may masquerade as post-dural puncture headache include intracranial tumours, 3 38 intracranial haematoma, 32 40 pituitary apoplexy, 77 cerebral venous thrombosis, 122 134 migraine, chemical or infective meningitis, 106 and nonspeci®c headache. It has been estimated that 39% of parturients report symptoms of a headache unrelated to dural puncture following delivery. 120 
Duration
The largest follow-up of post-dural puncture headache is still that of Vandam and Dripps in 1956. 132 They reported that 72% of headaches resolved within 7 days, and 87% had resolved in 6 months ( Table 3 ). The duration of the headache has remained unchanged since that reported in 1956. 26 In a minority of patients the headache can persist. 133 Indeed, case reports have described the persistence of headache for as long as 1±8 yr after dural puncture. 80 It is interesting to note that even post-dural puncture headaches of this duration have been successfully treated with an epidural blood patch. 106 Intracranial haemorrhage 65 94 104 Cerebral venous thrombosis 10 Intracranial tumour 3 38 Non-speci®c headache 44 Pituitary apoplexy 77 Cerebral infarction Uncal herniation 39 97 Sinus headache Migraine 76 Drugs (e.g. caffeine, amphetamine) Pre-eclampsia
Treatment
Overview
The literature regarding the treatment of post-dural puncture headache often involves small numbers of patients, or uses inappropriate statistical analysis. Studies observing the effects of treatments in post-dural puncture headache often fail to recognize that, with no treatment, over 85% of postdural puncture headaches will resolve within 6 weeks (Table 3) .
Psychological
Patients who develop post-dural puncture headache may reveal a wide range of emotional responses from misery and tears to anger and panic. It is important both from a clinical and medico-legal point of view, to discuss the possibility of headache before a procedure is undertaken that has a risk of this complication. Even so, this discussion will not prepare the patient for the sensations he or she feels should the headache develop. 133 Obstetric patients are particularly unfortunate should they develop this complication, as they expect to feel well and happy and to be able to look after their new baby. It is important to give the mother a thorough explanation of the reason for the headache, the expected time course, and the therapeutic options available. Regular review is essential to monitor the course and therapeutic manoeuvres undertaken.
Simple
Bed rest has been shown to be of no bene®t. 118 Supportive therapy such as rehydration, acetaminophen, non-steroidal anti-in¯ammatory drugs, opioids, and antiemetics may control the symptoms and so reduce the need for more aggressive therapy, 89 but do not provide complete relief. 44 
Posture
If a patient develops a headache, they should be encouraged to lie in a comfortable position. The patient will often have identi®ed this, without the intervention of an anaesthetist. There is no clinical evidence to support the maintenance of the supine position before or after the onset of the headache as a means of treatment. 68 The prone position has been advocated, but it is not a comfortable position for the post-partum patient. The prone position raises the intraabdominal pressure, which is transmitted to the epidural space and may alleviate the headache. A clinical trial of the prone position following dural puncture failed to demonstrate a reduction in post-dural puncture headache. 55 
Abdominal binder
A tight abdominal binder raises the intra-abdominal pressure. The elevated intra-abdominal pressure is transmitted to the epidural space and may relieve the headache. Unfortunately, tight binders are uncomfortable and are seldom used in current practice. There are few units that would recommend this approach. 86 
Pharmacological treatment
The aim of management of post-dural puncture headache is to: (i) replace the lost CSF; (ii) seal the puncture site; and (iii) control the cerebral vasodilatation.
A number of therapeutic agents have been suggested for the management of post-dural puncture headache. The main problem in choosing the most appropriate one is the lack of large, randomized, controlled clinical trials.
DDAVP, ACTH
A report in 1964 identi®ed 49 methods for treating postspinal headache. 127 There appears to be no limit to the imagination of physicians in treatments offered for postspinal headache. However, there is a lack of statistical data to support their ideas. Regarding DDAVP (desmopressin acetate), intramuscular administration before lumbar puncture was not shown to reduce the incidence of post-dural puncture headache. 57 ACTH (adrenocorticotrophic hormone) 21 has been administered as an infusion (1.5 mg kg
±1
), but inadequate statistical analysis prevents assessment of the value of ACTH.
Caffeine
Caffeine is a central nervous system stimulant that amongst other properties produces cerebral vasoconstriction. I.V. caffeine 0.5 g was recommended as a treatment of postdural puncture headache in 1944. 62 It is available in an oral and i.v. form. The oral form is well absorbed with peak levels reached in 30 min. Caffeine crosses the blood±brain barrier and the long half-life of 3±7.5 h allows for infrequent dosing schedules.
The most frequently quoted work on the treatment of post-dural puncture headache with caffeine is that of Sechzer. 113 114 He evaluated the effects of one or two 0.5 g doses of i.v. caffeine on subjects with established post-dural puncture headache. There are some statistical and methodological¯aws in this study, but it was concluded that i.v. Post-dural puncture headache caffeine is an effective therapy for post-dural puncture headache.
Dose
The dose now recommended for the treatment of post-dural puncture headache is 300±500 mg of oral or i.v. caffeine once or twice daily. 12 66 One cup of coffee contains about 50±100 mg of caffeine and soft drinks contain 35±50 mg. The LD 50 for caffeine is of the order of 150 mg kg ±1 . However, therapeutic doses have been associated with central nervous system toxicity, 9 and atrial ®brillation.
Mode of action
It is assumed that caffeine acts through vasoconstriction of dilated cerebral vessels. 12 If cerebral vasodilatation were the source of the pain, cerebral vasoconstriction might limit the pain experienced. Indeed, it has been demonstrated that caffeine causes a reduction in cerebral blood¯ow, 116 but this effect is not sustained. Caffeine therapy is simple to administer compared with the technical skills required to perform an epidural blood patch. Were caffeine as successful as suggested by previous reports, it would no doubt be widely advocated. However, a North American hospital survey of the treatment of post-dural puncture headache identi®ed that most hospital practitioners had abandoned the use of caffeine as they had found it ineffective. 8 The effects of caffeine on post-dural puncture headache seem, at best, temporary. 12 In addition, caffeine is not a therapy without complications, 9 and does not restore normal CSF dynamics, thus leaving the patient at risk from the serious complications associated with low CSF pressure.
Sumatriptan
The treatment for migranous headaches has focused on modi®cation of cerebral vascular tone. Sumatriptan is a 5-HT 1D receptor agonist that promotes cerebral vasoconstriction, in a similar way to caffeine. 123 Sumatriptan is advocated for the management of migraine and recently, for post-dural puncture headache. There have been only a few case reports where sumatriptan was used successfully to manage post-dural puncture headache. 61 However, a recent controlled trial found no evidence of bene®t from Sumatriptan for the conservative management of postdural puncture headache. 23 
Epidural blood patch History
After the observation that`bloody taps' were associated with a reduced headache rate, 51 the concept of the epidural blood patch has developed. The theory is that the blood, once introduced into the epidural space, will clot and occlude the perforation, preventing further CSF leak. The high success rate and the low incidence of complications have established the epidural blood patch as the standard against which to evaluate alternative methods to treat postdural puncture headache.
Technique
The presence of fever, infection on the back, coagulopathy, or patient refusal are contraindications to the performance of an epidural blood patch. 1 As a precautionary measure, a sample of the subject's blood should be sent to microbiology for culture. 27 With the patient in the lateral position, the epidural space is located with a Tuohy needle at the level of the supposed dural puncture or an intervertertebral space lower. The operator should be prepared for the presence of CSF within the epidural space. Up to 30 ml of blood is then taken from the patient's arm and injecting slowly through the Tuohy needle. Should the patient describe lancinating pain of dermatomal origin the procedure must be stopped. 27 There is no consensus as to the precise volume of blood required. Most practitioners now recognise that the 2±3 ml of blood originally described by Gormley is inadequate, and that 20±30 ml of blood is more likely to guarantee success. 27 Larger volumes, up to 60 ml, 97 have been used successfully in cases of spontaneous intracranial hypotension. At the conclusion of the procedure, the patient is asked to lie still for one 1 33 or, preferably, 2 h, 81 and is then allowed to walk.
Contraindications
Contraindications include those that normally apply to epidurals, but include a raised white cell count, pyrexia and technical dif®culties. Limited experience with HIV-positive patients suggest that it is acceptable providing no other bacterial or viral illnesses are active. 126 Epidural blood patch following diagnostic lumbar puncture in the oncology patient raises the potential for seeding the neuroaxis with neoplastic cells. One case has been reported of a successful patch without complications, 109 and one case 11 where the risks of central nervous system (CNS) seeding of leukaemia were considered to outweigh the bene®ts of an epidural blood patch.
The blood patch
Using either radiolabelled red cells 124 or an MRI scan, 7 several studies have reported the degree of spread of the epidural blood patch. After injection, blood is distributed caudally and cephalad regardless of the direction of the bevel of the Tuohy needle. The blood also passes circumferentially around to the anterior epidural space. The thecal space is compressed and displaced by the blood. In addition, the blood passes out of the intervertebral foramina and into the paravertebral space. The mean spread of 14 ml of blood is six spinal segments cephalad and three segments caudad. Compression of the thecal space for the ®rst 3 h, and a presumed elevation of subarachnoid pressure, may explain the rapid resolution of the headache.
Compression of the thecal sac is not, however, sustained and maintenance of the therapeutic effect is likely to be attributable to the presence of the clot eliminating the CSF leak. It has been observed that CSF acts as a procoagulant, accelerating the clotting process. 24 At 7±13 h, there is clot resolution leaving a thick layer of mature clot over the dorsal part of the thecal sac. Animal studies have demonstrated that 7 days after the administration of an epidural blood patch, there is widespread ®broblastic activity and collagen formation. 34 74 Fortunately, the presence of blood does not initiate an in¯ammatory process and there is no evidence of axonal oedema, necrosis or demyelination.
Outcome
The technique has a success rate of 70±98% if carried out more than 24 h after the dural puncture. 1 If an epidural blood patch fails to resolve the headache, repeating the blood patch has a similar success rate. Failure of the second patch and repeating the patch for a third or fourth time has been reported. However, in the presence of persistent severe headache, an alternative cause should be considered.
Complications
Immediate exacerbation of symptoms and radicular pain have been described. 136 These symptoms do not persist and resolve with the administration of simple painkillers. Longterm complications of epidural blood patch are rare. A single case report of an inadvertent subdural epidural blood patch described non-postural, persistent headache and lower extremity discomfort. 103 The issue of the effect of the blood patch on the success of subsequent epidurals has been addressed. 2 60 Though case reports describe limited spread of epidural analgesia 99 after previous epidural blood patch, a large retrospective study over a 12-yr period 60 found that subsequent epidural analgesia was successful in >96% of patients.
Prophylactic epidural blood patch
Where the known incidence of post-dural puncture headache is high, such as in the parturient, the use of a prophylactic epidural blood patch after accidental dural puncture, that is blood patching before the onset of symptoms, is an attractive option. Prophylactic patching has generally been dismissed as ineffective, but the evidence is con¯icting. A controlled trial in post-myelogram headaches, 54 and one after spinal anaesthesia and after unintentional dural puncture with an epidural needle, 22 have con®rmed the bene®t of prophylactic patching. Those studies that have not supported the use of prophylactic patching may have used insuf®cient blood for the patch. 22 The pressure gradient between the thecal and epidural space may be high immediately after dural puncture and lead to patch separation from the site of the perforation. Blood patching at that time may therefore need a greater volume of blood to produce a successful patch compared with a late patch, where the CSF pressure may be lower.
Chronic headache
Patients may present with features of a post-spinal headache never having received an epidural or spinal injection. A report of six such cases, with headaches that had been present between 1 and 20 yr, showed complete relief of headache following lumbar epidural blood patch. 91 It is interesting to speculate that these headaches may have been attributable to unidenti®ed spontaneous intracranial hypotension.
Epidural saline
Concerns have been expressed about the potential danger of an autologous epidural blood patch for the treatment of postdural puncture headache. The immediate resolution of the headache with a blood patch is attributable to thecal compression raising the CSF pressure. An epidural injection of saline would, in theory, produce the same mass effect, and restore normal CSF dynamics. As saline is a relatively inert and sterile solution, epidural saline bolus or infusion appears to be an attractive alternative. Regimens that have been advocated include: (i) 1.0±1.5 litre of epidural Hartmanns solution over 24 h, starting on the ®rst day after dural puncture; 28 84 121 (ii) up to 35 ml h ±1 of epidural saline or Hartmanns solution for 24±48 h, or after development of the headache; (iii) a single 30 ml bolus of epidural saline after development of headache; 5 84 and (iv) 10±120 ml of saline injected as a bolus via the caudal epidural space. 6 129 Advocates of an epidural saline bolus or infusion maintain that the lumbar injection of saline raises epidural and intrathecal pressure. Reduction in the leak would allow the dura to repair. However, observations of the pressures produced in the subarachnoid and epidural space show that, despite a large rise in epidural pressure, the consequent rise in subarachnoid pressure maintains the differential pressure across the dura. The pressure rise is also not sustained and is dissipated within 10 min. 129 The saline may induce an in¯ammatory reaction within the epidural space, promoting closure of the dural perforation. Histological studies have not demonstrated an in¯ammatory response following epidural Dextran 40 administration, however, in contrast to an autologous blood patch. 74 There is no reason to suppose that epidural saline is more likely to accelerate dural healing through a proin¯ammatory action than Dextran 40. Thus, there are no studies that are able to demonstrate either a sustained rise in CSF pressure or accelerated closure of the dural perforation after the administration of epidural saline. Whilst there are many case reports describing the success of epidural saline, comparative trials with epidural blood patches have not demonstrated the long-term ef®cacy of epidural saline placement. 5 It is dif®cult to conclude from the evidence therefore, that epidural saline administration will restore normal CSF dynamics. The administration of large volumes of epidural saline may result in intraocular haemorrhages through a precipitous rise in intracranial pressure. 19 
Epidural dextran
Despite the paucity of evidence to support epidural saline, some observers have considered the epidural administration of Dextran 40. 117 Those studies that recommend Dextran 40, either as an infusion or as a bolus, conclude that the high molecular weight and viscosity of Dextran 40 slows its removal from the epidural space. The sustained tamponade around the dural perforation allows spontaneous closure. However, it is unlikely that Dextran 40 will act any differently to saline in the epidural space. Any pressure rise within the subarachnoid space would, like saline, be only transient. Histological inspection of the epidural space after administration of Dextran 40, 74 does not demonstrate any in¯ammatory response that would promote the healing process. The evidence for the administration of epidural Dextran to treat post-dural puncture headache is not proven and the theoretical argument to justify its use is poor.
Epidural, intrathecal and parenteral opioids
A number of authors have advocated the use of epidural, 42 intrathecal 20 or parenteral morphine; 41 the majority of these reports are either case reports or inadequately controlled trials. Some of the studies used epidural morphine after the onset of headache, others used epidural or intrathecal morphine as prophylaxis or in combination with an intrathecal catheter. 20 A controlled trial of intrathecal fentanyl as prophylaxis found no evidence of a reduction in the incidence of post-spinal headache after dural puncture with a 25-gauge spinal needle. 31 
Fibrin glue
Alternative agents to blood, such as ®brinous glue, have been proposed to repair spinal dural perforations. 48 Cranial dural perforations are frequently repaired successfully with it. In the case of lumbar dural perforation, the ®brin glue may be placed blindly or using CT-guided percutaneous injection. 92 There is, however, a risk of the development of aseptic meningitis with this procedure. 111 In addition, manufacturers have recently warned against the application of some types of tissue glue where it may be exposed to nervous tissue. 110 
Intrathecal catheters
After accidental dural perforation with a Tuohy needle, it has been suggested that placement of a spinal catheter through the perforation may provoke an in¯ammatory reaction that will seal the hole. Evidence to support this claim is con¯icting. 30 135 The mean age of the patients in some of the trials has been >50 yr, where the rate of postdural puncture headache is low. Some trials have used spinal microcatheters, 26G±32G; others have placed 20G epidural catheters through an 18G Tuohy needle.
Histopathological studies in animals and humans with long-term intrathecal catheters con®rm the presence of an in¯ammatory reaction at the site of the catheter. Comparison between the effects of a catheter left in situ for 24 h and for several days or weeks would seem inappropriate. 96 If, after accidental dural puncture with a Tuohy needle, the insertion of an intrathecal catheter reduced the post-dural puncture headache rate, then it would be worth considering. However, neurological complications, such as cauda equina syndrome and infection, should preclude the use of intrathecal catheters.
Surgery
There are case reports of persistent CSF leaks, that are unresponsive to other therapies, being treated successfully by surgical closure of the dural perforation. 58 This is clearly a last resort treatment.
Conclusions
Post-dural puncture headache is a complication that should not to be treated lightly. There is the potential for considerable morbidity, 10 even death. 39 104 In the majority of cases, the problem will resolve spontaneously. In some patients, the headache lasts for months or even years.
Therapies that have been offered have not always arisen through the application of logic or reasoning. Gormley's observation that bloody taps were less likely to give rise to headaches, though probably incorrect, 71 has led to the widespread application of blood patching for the treatment of post-dural puncture headache. The bene®t of prophylactic blood patching is not so clear but deserves consideration in those most at risk from a headache, such as the parturient, and after accidental dural perforation with a Tuohy needle. There are occasions when blood patches appear to be ineffective in treating the headache. It is wise to consider other causes of the headache before applying alternative therapeutic options. Surgical closure of the dural tear is an option of last resort.
